- Investigator
- Michael D Schweitzer Barrios
- Ages
- 40 Years - 80 Years
- Sexes
- All
Clinical trials
-
Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) -
蹤獲扦 JAX Hernia Outcomes Data Bank - Investigator
- Jana M Sacco
- Ages
- 18 Years - N/A
- Sexes
- All
-
Selatogrel Outcome Study in suspected Acute Myocardial Infarction (SOS-AMI) - Investigator
- Francesco Franchi
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC who are BCG Na簿ve/Received Incomplete BCG Treatment - Investigator
- Kethandapatti Balaji
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
TAILOR BLEED - Investigator
- Dominick J Angiolillo
- Ages
- N/A
- Sexes
- All
-
Phase III, randomized, double-blind, placebo-controlled study to assess BI 1291583 2.5 mg once daily for up to 76 weeks in patients with bronchiectasis - Investigator
- Michael D Schweitzer Barrios
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE) - Investigator
- Gurjit S Kaeley
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
REducing future fractureS and improving ouTcOmes of fRagility fracturE - Investigator
- Porter F Young
- Ages
- 50 Years - 100 Years
- Sexes
- All
-
Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer - Investigator
- Dheeraj R Gopireddy
- Ages
- N/A
- Sexes
- All